Journal of Gynecology Obstetrics and Human Reproduction, Год журнала: 2023, Номер 53(1), С. 102693 - 102693
Опубликована: Ноя. 19, 2023
Язык: Английский
Journal of Gynecology Obstetrics and Human Reproduction, Год журнала: 2023, Номер 53(1), С. 102693 - 102693
Опубликована: Ноя. 19, 2023
Язык: Английский
Journal of Clinical Medicine, Год журнала: 2022, Номер 11(14), С. 4045 - 4045
Опубликована: Июль 13, 2022
The intrauterine environment is key to health from a short- and long-term perspective. Birth weight an important indicator that may influence the fetal due epigenetics. Considering physical inactivity, in parallel with higher levels of stress, affecting smoking patterns emotional pregnant population, maintaining future generations crucial. A randomized clinical trial (NCT04563065) was conducted. One-hundred ninety-two healthy individuals were assigned intervention (IG) or control (CG) group. Overall, significant differences found between groups when stratified by birth (χ2 (1) = 6.610; p 0.037) low macrosomia more often CG (4% vs. 14% 3% 9%, respectively) admissions neonatal intensive care unit 5.075; 0.024) (20/28.6%) compared IG (9/13.0). Smoking during pregnancy also (12/17.1%) (3/4.4%) (p 0.016). virtual program supervised exercise throughout ongoing pandemic could help maintain adequate weights, modify maternal habits, lower unit.
Язык: Английский
Процитировано
29Vaccines, Год журнала: 2023, Номер 11(8), С. 1289 - 1289
Опубликована: Июль 27, 2023
The anti-SARS-CoV-2 vaccination is recommended for pregnant women due to the high risk of complications. However, pregnancy has been associated with vaccine hesitancy. Our review aims at summarizing existing literature about hesitancy in and lactating women. research was conducted on PubMed/MEDLINE, ExcerptaMedica Database (EMBASE), Scopus, according PRISMA guidelines. Articles regarding COVID-19 vaccine's acceptance and/or refusal by were selected. Only observational, population-based studies included. Joanna Briggs Institute quality assessment tools employed. A total 496 articles retrieved, after selection process, 21 papers included current analysis. All cross-sectional, mostly from Europe North America. sample sizes ranged between 72 25,111 subjects. them subjects, except one that focused breastfeeding only. Vaccine rates 26% 57% among different studies. Fear adverse events lack knowledge shown be main drivers Approximately half (11/21) classified as low quality, remaining (9/21) moderate, only study quality. Primigravidae also more likely accept vaccination. findings confirm significant Information gaps should addressed contain concerns related events.
Язык: Английский
Процитировано
15Journal of Personalized Medicine, Год журнала: 2023, Номер 13(5), С. 797 - 797
Опубликована: Май 6, 2023
Pregnant women are more prone to experience severe COVID-19 disease, including intensive care unit (ICU) admission, use of invasive ventilation, extracorporeal membrane oxygenation (ECMO), and mortality compared non-pregnant individuals. Additionally, research suggests that SARS-CoV-2 infection during pregnancy is linked adverse outcomes, such as preterm birth, preeclampsia, stillbirth, well neonatal hospitalization admission the unit. This review assessed available literature from November 2021 19 March 2023, concerning safety effectiveness vaccination pregnancy. administered not significant events related vaccine or negative obstetric, fetal, outcomes. Moreover, has same in preventing disease pregnant individuals general population. safest most effective method for protect themselves their newborns hospitalization, ICU admission. Thus, should be recommended patients. While immunogenicity appears similar population, needed determine optimal timing benefit neonate.
Язык: Английский
Процитировано
9Archives of Clinical Infectious Diseases, Год журнала: 2025, Номер 20(2)
Опубликована: Янв. 18, 2025
Background: There are ongoing controversies regarding pregnancy outcomes during the COVID-19 era. Objectives: This observational study with a retrospective design was conducted to investigate maternal and neonatal impacts of on outcomes. Methods: An carried out using census sampling from February 2020 July 2021. The population included pregnant women who were referred Asalian Hospital in Khorramabad city, western Iran. A total 769 mothers (107 662 without COVID-19) study. Results: most common symptoms reported by infected body pain/myalgia (68, 72.3%), fatigue (57, 60.6%), headache (47, 50%), shivering (46, 48.9%). After adjusting for covariates, risk caesarean section (CS) found be 3.2 times higher (95% confidence interval: 1.90 - 5.50). In contrast, risks newborn hospitalization, prematurity, low APGAR scores, respiratory distress, smaller head circumference among newborns non-COVID-19-infected than those COVID-19-infected (P < 0.05). Conclusions: While it is generally expected that would experience adverse outcomes, this demonstrated infection does not result or newborns, apart rate CS.
Язык: Английский
Процитировано
0Birth Defects Research, Год журнала: 2025, Номер 117(2)
Опубликована: Фев. 1, 2025
Vaccinations in pregnancy are an essential part of prenatal care and play a critical role protecting both pregnant persons their infants from certain infectious diseases. In the United States, recommendations for vaccines made through comprehensive review currently available scientific literature, including clinical trials post-marketing surveillance data, by Advisory Committee on Immunization Practices (ACIP). The ACIP is advisory committee to US Centers Disease Control Prevention (CDC), comprised medical public health experts who develop evidence-based guidelines vaccinations, persons. has several work groups that evidence ongoing basis, full-committee meetings held at least three times year. As more data regarding safety efficacy become available, these continue evolve. To recommendations, carefully considers risks exposure agents against potential vaccination. We here current vaccinations use Recommendations divided into four categories: recommended during pregnancy, under circumstances, not or contraindicated without specific recommendations. ensure optimal healthcare providers need be familiar with
Язык: Английский
Процитировано
0Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Апрель 15, 2025
Background Given the physiological hemostasis changes during pregnancy, limited data exists on COVID-19-induced inflammatory response and alterations in pregnant women. Objectives To test a comprehensive set of cytokines pregnancies with/without COVID-19 correlate results with maternal perinatal outcomes. Patients/methods In this observational case-control study, 100 women acute at 24-40 gestational weeks (COVID-19+ group), healthy, age- week-matched, SARS-CoV-2 negative (32 proven recovery COVID-19) were enrolled. All outpatients mild/no symptoms admission. Detailed (fibrinogen, FVIII, FXIII, VWF, plasminogen, α2-plasmin inhibitor, PAI-1, thrombin generation, clot lysis, D-dimer) cytokine/chemokine panels performed. Clinical parameters labor postpartum period registered. Results COVID-19+ exhibited significantly lower higher VWF levels, decreased peak enhanced lysis vs. controls. Despite symptoms, elevated cytokine including IL-6, INF-γ, MCP-1, IL-18 observed pregnancies, associated distinct alterations. Admission IL-1β, IL-33 lower, while was cases when became more severe, along FXIII plasminogen. group, hemorrhage (PPH) developed 4 cases, reduced increased IL-8, IL-17A, IL-23 levels. Conclusion third trimester mild/asymptomatic marked changes, fibrinolysis found. A potential link between inflammation PPH context warrants further research.
Язык: Английский
Процитировано
0American Journal Of Pathology, Год журнала: 2025, Номер unknown
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Май 8, 2025
Язык: Английский
Процитировано
0Brain Behavior and Immunity, Год журнала: 2023, Номер 112, С. 188 - 205
Опубликована: Июнь 16, 2023
Whether or not SARS-CoV-2 can cross from mother to fetus during a prenatal infection has been controversial; however, recent evidence such as viral RNA detection in umbilical cord blood and amniotic fluid, well the discovery of additional entry receptors fetal tissues suggests potential for transmission fetus. Furthermore, neonates exposed maternal COVID-19 later development have displayed neurodevelopmental motor skill deficiencies, suggesting consequential neurological inflammation utero. Thus, we investigated consequences on developing brain using human ACE2 knock-in mice. In this model, found that tissues, including brain, occurred at developmental stages, primarily targeted male fetuses. largely within vasculature, but also other cells neurons, glia, choroid plexus cells; replication increased cell death were observed tissues. Interestingly, early gross differences between infected mock-infected offspring, high levels gliosis seen brains 7 days post initial despite clearance time point. pregnant mice, more severe infections, with greater weight loss dissemination compared non-pregnant Surprisingly, did observe an increase antiviral IFN response these showing clinical signs disease. Overall, findings concerning implications regarding neurodevelopment pregnancy complications following exposure.
Язык: Английский
Процитировано
8Biomedicines, Год журнала: 2023, Номер 11(12), С. 3105 - 3105
Опубликована: Ноя. 21, 2023
COVID-19 was an infection that capable of bringing the entire world to a standstill position within period days months. Despite advancements in medical sector, contagion difficult control and costed lives millions people worldwide. Many short- long-term effects are witnessed even date contracted disease. Pregnant females had suffer not only devastating virus, but also psycho-social impact lockdown. The during pregnancy causing decreased antenatal care or hypoxemic episodes due severe respiratory distress whether it could lead appearance congenital gastrointestinal malformation neonates is still unclear. aim our study analyze if increase incidence gastric malformations born from these women.We sifted files all admitted into hospital between January 2022 December 2022, based on inclusion exclusion criteria, we included cases having pandemic. We performed single-center, retrospective, observational descriptive study. further divided patients anatomical location malformation. took down details evolution mother SARS-CoV-2 pregnancy. Details regarding Apgar score, intensive admission, sex, nutrition were key findings studied.A total 47 found have digestive anomalies, among which, locations, number at level esophagus 15, while 16 occurred pylorus; 12 duodenum, four rectum. Out neonates, 38.3% 61.7% males. A 58% preemies, which 9% intra-uterine growth retardation (IUGR), 42% full-term newborns, 4% (IUGR). 45% births primiparous pregnancies 55% multiparous females. 14 mothers tested positive for course (p-value = 0.23); many mild symptoms tested.COVID-19 can affect wellbeing pregnant female their fetus. Larger studies help gain extensive knowledge as has potential result anomalies children mothers. In study, few infants with this pathology be Hence, conclude exclude direct correlation malformations.
Язык: Английский
Процитировано
6